Haloperidol affects bones while clozapine alters metabolic parameters - sex specific effects in rats perinatally treated with phencyclidine

Abstract Background The presentation of schizophrenia (SCH) symptoms differs between the sexes. Long-term treatment with antipsychotics is frequently associated with decreased bone mineral density, increased fracture risk and metabolic side effects. Perinatal phencyclidine (PCP) administration to ro...

Full description

Saved in:
Bibliographic Details
Main Authors: Tatjana Nikolić (Author), Milan Petronijević (Author), Jelena Sopta (Author), Milica Velimirović (Author), Tihomir Stojković (Author), Gordana Jevtić Dožudić (Author), Milan Aksić (Author), Nevena V. Radonjić (Author), Nataša Petronijević (Author)
Format: Book
Published: BMC, 2017-10-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_b11b0e60efc74e158cb4cfd8f85aad84
042 |a dc 
100 1 0 |a Tatjana Nikolić  |e author 
700 1 0 |a Milan Petronijević  |e author 
700 1 0 |a Jelena Sopta  |e author 
700 1 0 |a Milica Velimirović  |e author 
700 1 0 |a Tihomir Stojković  |e author 
700 1 0 |a Gordana Jevtić Dožudić  |e author 
700 1 0 |a Milan Aksić  |e author 
700 1 0 |a Nevena V. Radonjić  |e author 
700 1 0 |a Nataša Petronijević  |e author 
245 0 0 |a Haloperidol affects bones while clozapine alters metabolic parameters - sex specific effects in rats perinatally treated with phencyclidine 
260 |b BMC,   |c 2017-10-01T00:00:00Z. 
500 |a 10.1186/s40360-017-0171-4 
500 |a 2050-6511 
520 |a Abstract Background The presentation of schizophrenia (SCH) symptoms differs between the sexes. Long-term treatment with antipsychotics is frequently associated with decreased bone mineral density, increased fracture risk and metabolic side effects. Perinatal phencyclidine (PCP) administration to rodents represents an animal model of SCH. The aim of this study was to assess the effects of chronic haloperidol and clozapine treatment on bone mass, body composition, corticosterone, IL-6 and TNF-α concentrations and metabolic parameters in male and female rats perinatally treated with PCP. Methods Six groups of male and six groups of female rats (n = 6-12 per group) were subcutaneously treated on 2nd, 6th, 9th and 12th postnatal day (PN), with either PCP (10 mg/kg) or saline. At PN35, one NaCl and PCP group (NaCl-H and PCP-H) started receiving haloperidol (1 mg/kg/day) and one NaCl and PCP group (NaCl-C and PCP-C) started receiving clozapine (20 mg/kg/day) dissolved in drinking water. The remaining NaCl and PCP groups received water. Dual X-ray absorptiometry measurements were performed on PN60 and PN98. Animals were sacrificed on PN100. Femur was analysed by light microscopy. Concentrations of corticosterone, TNF-α and IL-6 were measured in serum samples using enzyme-linked immunosorbent assay (ELISA) commercially available kits. Glucose, cholesterol and triacylglycerol concentrations were measured in serum spectrophotometrically. Results Our results showed that perinatal PCP administration causes a significant decrease in bone mass and deterioration in bone quality in male and female rats. Haloperidol had deleterious, while clozapine had protective effect on bones. The effects of haloperidol on bones were more pronounced in male rats. It seems that the observed changes are not the consequence of the alterations of corticosterone, IL-6 and TNF-α concentration since no change of these factors was observed. Clozapine induced increase of body weight and retroperitoneal fat in male rats regardless of perinatal treatment. Furthermore, clozapine treatment caused sex specific increase in pro-inflammatory cytokines. Conclusion Taken together our findings confirm that antipsychotics have complex influence on bone and metabolism. Evaluation of potential markers for individual risk of antipsychotics induced adverse effects could be valuable for improvement of therapy of this life-long lasting disease. 
546 |a EN 
690 |a Schizophrenia 
690 |a Bone mineral density 
690 |a Haloperidol 
690 |a Clozapine 
690 |a Corticosterone 
690 |a Phencyclidine 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
690 |a Toxicology. Poisons 
690 |a RA1190-1270 
655 7 |a article  |2 local 
786 0 |n BMC Pharmacology and Toxicology, Vol 18, Iss 1, Pp 1-17 (2017) 
787 0 |n http://link.springer.com/article/10.1186/s40360-017-0171-4 
787 0 |n https://doaj.org/toc/2050-6511 
856 4 1 |u https://doaj.org/article/b11b0e60efc74e158cb4cfd8f85aad84  |z Connect to this object online.